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Abstract Rat liver microsomes contain two distinct forms of 
Ptdlns 4-kinase which were resolved by heparin-Sepharose 
chromatography. One enzyme was identified as the type II Ptdlns 
kinase previously isolated from exocytotic vesicles. The other 
enzyme, however, was a novel Ptdlns 4-kinase isoform with prop- 
erties differing from any other Ptdlns kinase so far characterized. 
Both kinases were recognized by a monoelonal antibody specific 
for type lI Ptdlns 4-kinase, but the novel enzyme was considera- 
bly less sensitive to inhibition by adenosine and Ca z+ than type 
lI enzymes, and in addition was specifically inhibited by submilli- 
molar concentrations of dithioerythritol. The presence of a novel 
PtdIns 4-kinase isoform in rat liver raises the question of whether 
this enzyme is unique for this organ or whether it has a more 
widespread istribution but so far has avoided detection. 
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1. Introduction 
Ptdlns 4-kinase catalyses the first committed step in the for- 
mation of polyphosphoinositides. Increased turnover of pol- 
yphosphoinositides and second messenger production are key 
events in the transduction of hormonal, neuronal and growth 
factor signals in a wide variety of cells [1]. In addition to their 
roles as second messenger precursors there are now several 
lines of evidence which suggest hat the polyphosphoinositides 
may have other functions, for instance in regulation of enzyme 
activity [2] and control of cytoskeletal dynamics [3,4]. 
Two forms of Ptdlns 4-kinase have been identified in various 
tissues [5,6]. One of these, the type II PtdIns kinase [7], has been 
purified and characterized from several tissues [8-13], whereas 
the second isoform, the type III kinase, remains less well de- 
fined [14]. In rat liver a large fraction of the total Ptdlns 4- 
kinase activity resides in low-density membranes [15,16], now 
identified as exocytotic vesicles [17]. We have previously iso- 
lated and partly characterized this enzyme and shown it to be 
a type II kinase [18]. We now report the existence of an addi- 
tional, and novel, Ptdlns 4-kinase in rat liver with properties 
differing from both the type II kinase and all other Ptdlns 
4-kinases o far characterized. 
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2. Experimental 
2.1. Materials 
PtdIns, PtdIns4P and Ptdlns(4,5)P2 were prepared from Sigma Type 
I brain extract [19]. [y-32P]ATP was prepared as described [20]. Hepa- 
rin-Sepharose and the Mono S HR 5/5 column were from Pharmacia 
LKB Biotechnology (Sollentuna, Sweden), hydroxylapatite (fast flow) 
from Calbiochem (San Diego, USA) and reduced Triton X-100 from 
Aldrich (Steinheim, Germany). The monoclonal PtdIns 4-kinase anti- 
body was a gift from Dr. G. Endemann, Scios Nova Icr. (Mountain 
View, CA, USA). 
2.2. Purification of Ptdlns kinases 
Rat liver microsomes were prepared essentially as described in [21]. 
Liver tissue (16 g) was homogenized in 0.25 M sucrose, 5 mM Tris-HCl, 
pH 8.0 (3 vols/g wet wt.) using a loose-fitting Potter-Elvehjem homog- 
enizer. After centrifugation at 1000 x g for 10 min, the pellet obtained 
was re-extracted twice by homogenization a d centrifugation asabove. 
The combined supernatants were centrifuged at 27,000 x g for 10 rain 
and the pellet re-extracted once. Microsomal membranes were recov- 
ered from the 27,000 x g supernatant by centrifugation at 105,000 × g 
for 90 min. 
The microsomes were solubilized for 60 min at 4°C in 50 mM 
HEPES-NaOH, pH 7.2, 0.15 M KC1, 2 mM EGTA, 2 mM EDTA, 
1 mM phenylmethylsulfonyl fluoride and 2% (w/v) reduced Triton X- 
100 at a final protein concentration of 5 mg/ml and then centrifuged 
at 100,000 × g for 60 rain. The extract obtained, containing ca 300 mg 
of protein and more than 90% of the microsomal Ptdlns kinase activity, 
was diluted with an equal volume of 20 mM HEPES-NaOH, pH 7.2, 
20% (v/v) glycerol, 1 mM EGTA, 1 mM EDTA, 0.1 mM phenylmeth- 
ylsulfonyl fluoride and 0.2% (w/v) reduced Triton X-100 and applied 
to a heparin-Sepharose column (2.6 x 10 cm) equilibrated with this 
buffer mixture. After washing with 0.1 M NaCI in the buffer, adsorbed 
proteins were eluted with a 600-ml linear 0.1-1.0 M NaC1 gradient. 
Fractions containing the second of two peaks of Ptdlns kinase activity, 
eluting at 0.5 M NaC1, were combined and applied to a hydroxylapatite 
column (1 x 10 cm) equilibrated with 20 mM potassium phosphate, pH 
7.2, 20% (v/v) glycerol and 0.1% (w/v) reduced Triton X-100. After 
washing with this buffer, the enzyme was desorbed with a 60-ml linear 
20-500 mM potassium phosphate gradient in the buffer. Fractions with 
kinase activity, eluting as a single peak at 0.26 M potassium phosphate, 
were combined and dialysed against 20 mM potassium phosphate, pH 
6.8, 20% (v/v) glycerol, 1 mM EGTA and 0.1% (w/v) reduced Triton 
X-100, and applied to a Mono S H/R 5/5 column equilibrated with this 
buffer. After washing with 10 ml of buffer the enzyme was desorbed 
with a 25-ml linear 0-1.0 M NaCI gradient in the buffer. Fractions 
containing kinase activity, eluting as a single peak at 0.5 M NaCI, were 
combined and stored at -70°C (Ptdlns kinase B). 
For comparative studies rat liver Type II Ptdlns kinase was purified 
as described previously [18]. This enzyme is called Ptdlns kinase A. 
Preliminary experiments showed the first peak of microsomal Ptdlns 
kinase activity, eluting from heparin-Sepharose at 0.25 M NaC1, to have 
the same properties as the type II enzyme. Type III Ptdlns kinase was 
isolated from a cholate extract of rat brain membranes by sucrose 
density gradient centrifugation [27]. 
2.3. Assay of Ptdlns kinase activity 
The activity of Ptdlns kinase was measured as described earlier [18], 
except hat dithioerythritol was omitted when measuring Ptdlns kinase 
B. The substrate was presented as Ptdlns :Triton X- 100 mixed micelles. 
Lipids in chloroform were evaporated to dryness under a stream of 
nitrogen, Triton X-100 was added, the solution mixed vigorously and 
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sonicated for 10 min in a sonication bath (Branson 2200; Bransonic). 
All assays were performed induplicate and were in the linear ange with 
regard to protein concentration a d incubation time. The difference 
between i dividual incubations in a duplicate was typically less than 
2%. 
2 4. Isomeric onfiguration fPtdlnsP formed by Ptdlns kinases A
and B 
Bulk preparations of32P-labelled reaction products, obtained by the 
s:andard assay using prolonged incubation times (10 50 rain), were 
spiked with authentic [3H]Ptdlns4P (Amersham, UK) and deacylated 
[ ~.2]. The resulting lycerophosphoinositides were eparated by isocratic 
~IPLC using a Partisil 10-SAX column (Whatman, UK) and 100 mM 
NaH2PO4, pH 3.8, as eluant at a flow rate of 1.5 ml/min. Reproducibil- 
~':y between runs was ensured by inclusion of AMP and ADP as internal 
~tandards, monitored by their absorbance at 254 nm. Radioactivity was 
~ietermined by liquid scintillation spectrometry after addition of Hionic 
,cintillation fluid (Canberra-Packard, UK). Background radiation has 
,een subtracted from all data presented. 
.5. Other methods" 
Protein concentrations were determined [23] using bovine serum al- 
mmin as a standard. Concentrations of phospholipids in chloroform 
tock solutions were determined byphosphate contents [24]. The 4C5G 
gG fraction was purified from ascites fluid by binding to protein 
3-Agarose at pH 7.2 and eluting at pH 2.7 [25]. 
L Results 
~. 1. Presence of two .forms of Ptdlns k&ase in rat liver 
Exocytotic vesicles from rat liver contain a Ptdlns 4-kinase 
tctivity eluting as a single peak from heparin-Sepharose [18]. 
However, when rat liver microsomes, the crude source of ex- 
9cytotic vesicles, were solubilized in Triton X-100 and chroma- 
tographed on heparin-Sepharose th PtdIns kinase activity was 
resolved into two distinct peaks (Fig. 1). The first peak (PtdIns 
kinase A), representing approximately 70% of the total PtdIns 
kinase activity recovered, eluted at exactly the same salt con- 
zentration as PtdIns 4-kinase from exocytotic vesicles, while the 
second peak (PtdIns kinase B) eluted at a higher salt concentra- 
tion (0.5 M vs. 0.25 M NaCI). The PtdIns kinase activity of the 
first peak was stimulated by PtdCho and had several other 
properties in common with the enzyme isolated from exocytotic 
vesicles [l 8], whereas PtdIns kinase B had quite different prop- 
erties. As each enzyme form retained its specific elution behav- 
iour on re-chromatography on heparin-Sepharose, w  conclude 
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Fig. 1. Separation oftwo forms of Ptdlns kinase on heparin-Sepharose. 
Rat liver microsomes (300 mg of protein) were solubilised and chroma- 
tographed on heparin-Sepharose a  described insection 2. Ten-ml frac- 
tions were collected. Ptdlns kinase activity was determined in the pres- 
ence (o) or absence (©) of 1 mM PtdCho. Recovered activity was 
approximately 70%. Solid line, protein; dashed line, NaC1 gradient. 
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Fig. 2. Identification of reaction products. The 32P-labelled reaction 
products produced by Ptdlns kinases Band A (inset) were fortified with 
authentic [3H]PtdlnsP before deacylation and separation by isocratic 
HPLC as described in section 2. o, 32p label; ©, 3H-label of the 
standard. 
that rat liver microsomes indeed contain two distinct Ptdlns 
kinases. 
3.2. Purification of Ptdlns kinase B 
The second peak of Ptdlns kinase activity from heparin- 
Sepharose (Fig. 1) was further purified by chromatography on
hydroxylapatite and a Mono S column (see section 2), both 
steps yielding a single peak of PtdIns kinase activity. The final 
preparation had a specific activity of 7 nmol/min/mg protein, 
17-fold higher than the microsomal membranes and, in turn, 
50-fold higher than the liver homogenate. The yield was 8% of 
the total PtdIns kinase activity of the membranes (or 28% after 
subtracting the contribution of PtdIns kinase A, assuming the 
same recovery of the two enzymes on heparin-Sepharose 
chromatography). 
3.3. Identification of reaction product 
The isomeric onfiguration of the PtdlnsP produced by the 
PtdIns kinase B was investigated by isocratic HPLC analysis 
of [32p]GPtdInsP obtained by O--->N transacylation. The 
[32p]GPtdInsP derived from the product of PtdIns kinase B 
co-chromatographed exactly with authentic [3H]GPtdlns4P 
(Fig. 2), indicating the parent PtdInsP to be PtdIns4P. Thus, 
we conclude that rat liver PtdIns kinase B is a PtdIns 4-kinase. 
The same analysis, applied to the reaction product of the A- 
form (Fig. 2, inset), confirmed the previous identification f this 
enzyme as a type II PtdIns 4-kinase [18]. Both enzyme forms 
phosphorylated PtdIns specifically, as PtdIns4P and 
PtdIns(4,5)P2 were phosphorylated to less than 1% of that of 
PtdIns under equivalent incubation conditions. 
3.4. Effect of pH and divalent cations 
The pH curves for the two forms of Ptdlns kinase were 
similar, with maximum activity between pH 7 and 8 (not 
shown). The dependence on divalent cations differed, however, 
Ptdlns kinase B displayed maximum activity at 4 mM Mg 2+ 
(and above), and 1-1.5 mM Mn 2+ could only partly (20% of 
maximum) replace Mg 2+ (Fig. 3a). The A-form required 2 mM 
Mg 2+ for maximum activity, but, in this case 0.5 mM Mn 2+, 
efficiently (80%) substituted for Mg 2+. 
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Fig. 3. Effect of divalent cations. The activities of PtdIns 4-kinase A (e) 
and B (0) were measured at the indicated concentrations of (a) Mg 2+ 
(solid line) and Mn 2÷ (dashed line) ions and (b) Ca 2+ ions. Data are 
means of duplicate incubations with deviations less than 2% from the 
mean. 
Ptdlns kinase B was less sensitive to inhibition by Ca2+than 
the A-form, with IC50 values of 4.1 and 0.5 raM, respectively 
(Fig. 3b). Free Ca 2+ concentrations in the micromolar range (up 
to 200 pM; Ca2+-EGTA buffers) did not affect the enzyme 
activity. 
3.5. Effect of  dithioerythritol and the monoclonal ntibody 4C5G 
PtdIns kinase B was inhibited to 70-80% by dithioerythritol, 
with an ICs0 value as low as 0.6 raM, whereas the A-form 
remained unaffected (Fig. 4). Reduced glutathione also inhib- 
ited the B-form with an IC50 of 10 mM. p-Chloromercuriben- 
zoic acid at l0 / IM  inhibited both enzymes completely (not 
shown). 
The monclonal antibody 4C5G, raised to the type II Ptdlns 
4-kinase from bovine brain [27] at 100 pg/ml, inhibited both 
kinases by 70%, although the A-form was more sensitive at 
lower antibody concentrations (Fig. 5). Rat brain type III 
Ptdlns kinase was not recognized by the antibody, however 
(Fig. 5). This antibody was earlier shown to inhibit type II 
kinase from bovine brain [27] and other sources [8,28], but not 
type III kinase from bovine or rat brain, or type I Ptdlns 
3-kinase [27]. 
3.6. Lipid dependency 
PtdCho enhances the activity of PtdIns kinase A several-fold, 
whereas PtdSer is inhibitory [18]. These phospholipids, at the 
same concentration as in [18], did not affect the activity of 
PtdIns kinase B. 
3.7. Dependence on ATP and Ptdlns in Triton X-lOO.'Ptdlns 
mixed micelles 
Kinetic analyses were performed under defined conditions, 
where the substrate was presented as Triton X-100:PtdIns 
mixed micelles (cf. [10,29,30]). At a saturating bulk PtdIns con- 
centration of 0.2 mM, the enzyme activity was dependent only 
on the micellar surface concentration of PtdIns, which was 
varied by changing the Triton X-100 concentration. Under 
these conditions the two PtdIns kinases displayed saturation 
kinetics both for ATP and PtdIns. The Km value for ATP was 
78/.tM for the B-form compared to 40 pM for the A-form. 
Corresponding Km values for PtdIns were 3.4 mol% and 0.99 
mol% (3.3 tool% in the presence of PtdCho), respectively. 
3.8. Effect of  adenosine 
Adenosine inhibits Ptdlns 4-kinases from various sources to 
different degrees [7]. The rat liver B-form was rather insensitive 
to increasing concentrations of adenosine, being inhibited by 
only 15% by 0.5 mM of the nucleoside compared to 55% for 
the A-form, under the analysis conditions chosen (not shown). 
To obtain apparent K~ values for adenosine the Ptdlns sur- 
face concentration was kept constant at a saturating level (0.5 
mM bulk concentration, corresponding to a surface concentra- 
tion of 9 tool%) while the ATP concentration was varied at 
different set adenosine concentrations. As expected for compet- 
itive inhibition, adenosine did not affect the apparent Vmax 
values but caused an increase in the apparent K~ values for 
ATP (Fig. 6). Replots of these apparent K~ values (Kin,) vs. the 
adenosine concentration (Fig. 6, insets) were linear and gave K~ 
values for adenosine of 14 and 410/.tM for kinases A and B, 
respectively. 
4. Discussion 
We have isolated a new form of Ptdlns kinase from rat liver 
having properties distinct from an earlier isolated form. Both 
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Fig. 4. Effect of dithioerythritol onthe activities of Ptdlns 4-kinase A 
and B. The activities of Ptdlns 4-kinase A (e) and B (o) were measured 
as described in section 2 at the indicated concentrations of 
dithioerythritol. Data are means of duplicate incubations with devia- 
tions less than 2% from the mean. 
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forms of the enzyme are particulate and phosphorylate PtdIns 
in the 4-position. The new B-form was associated with so far 
ul]identified material present in the microsomal fraction, 
~ hereas the A-form was present in exocytotic vesicles derived 
from these microsomes [18]. 
Ptd]ns kinase B differed in properties from the A-form in 
s,~'veral respects. It was inhibited by dithioerythritol, was com- 
paratively insensitive to inhibition by adenosine and calcium 
i,,ns, and was affected only slightly by various phospholipids. 
l urthermore, it differed from the A-form in Km values for ATP 
~nd PtdIns and dose response curves to Mg2+/Mn -~÷ and the 
llonoclonal antibody 4C5G. These facts, together with the 
~ ifferent subcellular distribution of the two enzyme forms and 
t:le inability of PtdIns 4-kinase B to renature after SDS-gel 
t lectrophoresis, ndicate that they are distinct enzymes and that 
~,ne form is not derived from the other form by proteolysis. 
The A-form was identified as a type II PtdIns kinase by its 
~ensitivity to inhibition by adenosine and Ca 2+, its apparent 
~!]olecular mass of 56 kDa upon SDS-PAGE and renaturation, 
;nd its inhibition by the antibody 4C5G [7,27]. 
The B-form also differed from all the type IIl kinases identi- 
!ied to date. It had a Km for ATP of 78 ,uM and a K~ for 
,,denosine of 410/IM, both constants intermediate between 
, eported values for the type II and the type III enzymes [14]. 
Furthermore, it was inhibited up to 70% by the 4C5G antibody 
vhich did not affect the activity of the type Ill enzyme from 
at brain. The enzyme was excluded from a Superdex 200 gel 
iltration column, indicating a molecular mass above 600 kDa 
ruder conditions when the type III enzyme from bovine uterus 
5] and rat brain [26] elute at 220 and 80 kDa, respectively. This 
!)ehaviour of Ptdlns kinase B indicates that it is in an aggre- 
;ated form, probably also reflected by its refractiveness to
,,,xhaustive purification. In contrast o the A-form, Ptdlns ki- 
lase B activity could not be recovered after SDS-gel electro- 
~horesis and, therefore, the minimum olecular mass of PtdIns 
dnase B could not be determined by this method. 
Another novel aspect of PtdIns 4-kinase B, and also a prop- 
.:rty which clearly disinguished it from PtdIns kinase A, was its 
.;ensitivity to inhibition by dithioerythritol. The ICs0 value of 
).6 mM suggests that the enzyme may be regulated by the 
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Fig. 5. Effect of the monoclonal ntibody 4C5G on PtdIns 4-kinase 
activity. Ptdlns 4-kinase A (o) and B (o), and the type III enzyme (D) 
isolated from rat brain, were incubated for 30 rain at 4°C with the 
indicated concentrations of purified 4C5G before PtdIns 4-kinase activ- 
ity was assayed as described insection 2. Data are means of duplicate 
incubations with deviations less than 2% from the mean. 
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Fig. 6. Inhibition of PtdIns 4-kinase A and B by adenosine. The activity 
of Ptdlns 4-kinase A (a) and B (b) were measured as a function of the 
concentration f ATP at 0 (©), 0.05 (e), 0.10 ([]) and 0.20 (I) mM 
adenosine (a) and 0 (o), 0.25 (e), 0.50 (D) and 1.00 (I) mM adenosine 
(b), respectively. The concentration fPtdIns was 11 mol% (0.5 mM 
bulk concentration). The data are means of duplicate incubations and 
plotted as l/v(nmol -t x min x mg) vs. the reciprocal of each ATP con- 
centration. The insets are replots of the apparent Kin' values obtained 
in a and b, respectively, vs.the concentration f adenosine. The lines 
were drawn using least-squares analysis of the data. The intercepts with 
abscissa nd ordinate are also indicated by symbols. 
cellular redox state, also indicated by the inhibitory effect of 
physiological concentration f reduced glutathione. 
The presence of a second PtdIns 4-kinase (kinase B) distinct 
from the type II enzyme (kinase A), in rat liver cells raises 
several questions. One is whether this enzyme is unique to liver 
cells, carrying out some specific function in this organ, or 
whether B-kinase analogues are widespread ineukaryotes. An- 
other question, in view of the multiplicity of PtdIns-4 kinases, 
is how the different forms are related structurally toeach other. 
One possibility is that they are products of alternative splicing, 
although this is speculative so far due to the lack of structural 
data. A third question which needs addressing is that of the 
physiological roles of the A- and B-kinases. Some clues may lie 
in their different sensitivity to dithioerythritol, phospholipids 
and Ca 2÷, but a final assessment must await more detailed 
information about their subcellular distribution and in vivo 
activity. It is also possible that the kinases are part of distinct 
phosphoinositide signalling systems operating within the cell, 
286 H. Olsson et al./FEBS Letters 361 (1995) 282-286 
particularly as isolated cytoskeletons and nuclei each seem to 
contain a set of enzymes involved in phosphoinositide turnover 
[31-33]. 
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